Coherus BioSciences, Inc. (CHRS) Retained Earnings (Accumulated Deficit) USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Coherus BioSciences, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2013 to 2024.
  • Coherus BioSciences, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$1.48 B, a 4.18% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$1.48 B -$59.3 M -4.18% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$1.58 B -$238 M -17.7% Dec 31, 2023 10-Q 2024-05-09
Q3 2023 -$1.5 B -$217 M -16.9% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 -$1.46 B -$264 M -22.1% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 -$1.42 B -$271 M -23.7% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 -$1.34 B -$292 M -27.8% Dec 31, 2022 10-K 2024-03-15
Q3 2022 -$1.28 B -$279 M -27.7% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 -$1.2 B -$230 M -23.9% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 -$1.15 B -$210 M -22.5% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 -$1.05 B -$287 M -37.6% Dec 31, 2021 10-K 2023-03-06
Q3 2021 -$1 B -$232 M -30% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 -$966 M -$165 M -20.6% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 -$936 M -$76.3 M -8.88% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 -$763 M +$132 M +14.8% Dec 31, 2020 10-K 2022-02-23
Q3 2020 -$772 M +$162 M +17.3% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 -$800 M +$181 M +18.4% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 -$859 M +$145 M +14.5% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 -$895 M +$89.8 M +9.12% Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$934 M -$12 M -1.3% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 -$981 M -$118 M -13.6% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 -$1 B -$185 M -22.6% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 -$985 M -$209 M -27% Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$922 M -$196 M -27% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 -$863 M -$196 M -29.4% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 -$820 M -$208 M -33.9% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 -$775 M -$238 M -44.3% Dec 31, 2017 10-K 2019-02-28
Q3 2017 -$726 M -$265 M -57.4% Sep 30, 2017 10-Q 2017-11-06
Q2 2017 -$667 M -$122 M -22.4% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 -$612 M -$137 M -28.8% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 -$537 M -$127 M -31.1% Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$461 M -$104 M -29% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 -$545 M -$259 M -90.5% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 -$475 M -$248 M -109% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 -$410 M -$223 M -120% Dec 31, 2015 10-K 2017-03-14
Q3 2015 -$358 M -$200 M -127% Sep 30, 2015 10-Q 2015-11-10
Q2 2015 -$286 M Jun 30, 2015 10-Q 2015-08-10
Q1 2015 -$227 M Mar 31, 2015 10-Q 2015-05-11
Q4 2014 -$187 M -$87.1 M -87.5% Dec 31, 2014 10-K 2016-02-29
Q3 2014 -$158 M Sep 30, 2014 10-Q 2014-12-15
Q4 2013 -$99.6 M Dec 31, 2013 10-K 2015-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.